Imaging with [99mTc]HMPAO – a novel perspective: investigation of [99mTc]HMPAO leg muscle uptake in metabolic diseases

2021 ◽  
pp. 028418512110636
Author(s):  
Zita Képes ◽  
Márton Mikó ◽  
Kornél Kukuts ◽  
Regina Esze ◽  
Sándor Barna ◽  
...  
Keyword(s):  
Glucose Level ◽  
Metabolic Diseases ◽  
Standardized Uptake Value ◽  
Tracer Uptake ◽  
Metabolic Disturbances ◽  
Perception Threshold ◽  
Vascular Abnormalities ◽  
Leg Muscles ◽  
Hmpao Spect ◽  
99Mtc Hmpao

Background Sensitive imaging modalities in the diagnosis of microcircular complications of the lower extremities induced by metabolic diseases are becoming a focus of interest. Purpose To investigate the [99mTc]HMPAO uptake of the legs in type 2 diabetes mellitus (T2DM) and obesity, and to search for associations with clinical parameters and nerve conducting studies. Material and Methods A total of 57 patients with controlled T2DM and 46 obese participants without DM were enrolled in the study. [99mTc]HMPAO SPECT/CT examinations were performed to evaluate the radiopharmaceutical accumulation of the legs. For the quantitative assessment of tracer uptake, standardized uptake value (SUVpeak) was measured in fixed spheric volumes of interest placed on both sural muscles on the attenuation-corrected images. Measurement of current perception threshold applying Neurometer (NM-01/CPT) was used to evaluate peripheral nerve dysfunction. Laboratory parameters assessing the glucose homeostasis of the study participants were also measured. Results In the diabetic group, significantly lower leg SUV values were detected compared to the non-DM obese group (median: 0.517 vs. 0.607; P < 0.001). Body mass index (BMI) ( P < 0.0001), age ( P = 0.0283), HbA1c ( P = 0.0068), and glucose level ( P = 0.0044) proved to be significant predictors of muscle tracer uptake. Neurometer studies showed positive correlation with HbA1c levels in the T2DM group ( P = 0.0002). Conclusion We assume that [99mTc]HMPAO uptake of leg muscles is associated with microcirculation, so quantitative [99mTc]HMPAO SPECT/CT might be a sensitive method for evaluating lower limb microvascular alterations. BMI, age, HbA1c, and glucose level may be significant predictors of peripheral vascular abnormalities triggered by metabolic disturbances.

Absolute SPECT/CT quantification of cerebral uptake of 99mTc-HMPAO for patients with neurocognitive disorders

2016 ◽  
Vol 55 (04) ◽  
pp. 158-165 ◽  
Author(s):  
Friedrich Welz ◽  
James Sanders ◽  
Torsten Kuwert ◽  
Juan Maler ◽  
Johannes Kornhuber ◽  
...  
Keyword(s):  
Tissue Concentration ◽  
Tracer Uptake ◽  
Planar Imaging ◽  
Quantitative Spect ◽  
Dementia Patients ◽  
Hmpao Spect ◽  
Patient Groups ◽  
The Absolute ◽  
99Mtc Hmpao

SummaryIt was reported from planar imaging studies that the cerebral uptake of injected 99mTc-HMPAO activity is about 4–7% in humans. Recent work has shown that modern SPECT/ CT devices are able to quantify the tissue concentration of radioactivity in vivo in absolute units (Bq/ml), while avoiding the limitations of planar techniques. The aims of this study were (a) to determine the cerebral uptake of 99mTc-HMPAO in absolute units in SPECT/CT, (b) to investigate potential differences in absolute tracer uptake for patients suspected of dementia. Patients, methods: We performed 99mTc-HMPAO SPECT/CT in 65 patients with suspected dementia. 99mTc-HMPAO uptake was determined using a previously published quantitative SPECT/CT protocol. The absolute HMPAO uptake and the results of a regionalized analysis were compared for MMSE and NINCDS-ADRDA based patient groups. Results: The mean absolute uptake of 99mTc-HMPAO for our patient population was 4.3 ± 0.8% of the injected dose. The uptake, as well as the regionalized analysis yielded significantly different results for low ( 23) and high (>23) MMSE groups and also for some of the NINCDS-ADRDA groups. Conclusion: Our results show that the absolute cerebral uptake of 99mTc-HMPAO is in the range of previously reported results, obtained by planar techniques. Absolute uptake is significantly different between the patient groups.

Statistical Parametric Mapping of 99mTc-HMPAO-SPECT Images for the Diagnosis of Alzheimer's Disease: Normalizing to Cerebellar Tracer Uptake

NeuroImage ◽  
2002 ◽  
Vol 17 (3) ◽  
pp. 1193-1202 ◽  
Author(s):  
Darius Soonawala ◽  
Tania Amin ◽  
Klaus P. Ebmeier ◽  
J.Douglas Steele ◽  
Nadine J. Dougall ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Statistical Parametric Mapping ◽  
Tracer Uptake ◽  
Parametric Mapping ◽  
Hmpao Spect ◽  
99Mtc Hmpao ◽  
Spect Images

Vergleich von MRT- und SPECT-Befunden bei Patienten mit zerebraler Mikroangiopathie

1991 ◽  
Vol 30 (05) ◽  
pp. 161-169 ◽  
Author(s):  
C. Weiller ◽  
R. Weigmann ◽  
H.-J. Kaiser ◽  
U. Büll ◽  
R. Schneider ◽  
...  
Keyword(s):  
White Matter Lesions ◽  
Central Nervous System Disease ◽  
Deep White Matter ◽  
Cranial Ct ◽  
System Disease ◽  
Ct Findings ◽  
Hmpao Spect ◽  
Significant Difference ◽  
Cerebral Microangiopathy ◽  
99Mtc Hmpao

Lacunar infarctions and periventricular hypodensity are assumed to be typical CT patterns of cerebral microangiopathy (MA). In 17 patients with such findings and in 6 controls without any signs of central nervous system disease cranial CT, MRT and 99mTc-HMPAO-SPECT were employed. In 7 patients with CT findings of minor MA demonstrated in comparison to controls no significant difference. In 10 cases with CT findings of pronounced MA periventricular rCBF was significantly reduced compared to controls. rCBF of temporal and parietal cortex were not diminished compared to controls. In 14 patients studied with MRT deep white matter lesions were found which appeared solitary, multiple or confluent. Employing 99mTc-HMPAO-SPECT, cerebral MA revealed rCBF reduction in periventricular brain tissue by cerebellar standardization.

SPECT-Befunde bei Hemiparkinson-Syndrom mit 99mTc-HMPAO

1989 ◽  
Vol 28 (03) ◽  
pp. 92-94 ◽  
Author(s):  
C. Neumann ◽  
H. Baas ◽  
R. Hefner ◽  
G. Hör
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Basal Ganglia ◽  
Neuronal Activity ◽  
Tracer Uptake ◽  
The Body ◽  
99Mtc Hmpao ◽  
Do So

The symptoms of Parkinson’s disease often begin on one side of the body and continue to do so as the disease progresses. First SPECT results in 4 patients with hemiparkinsonism using 99mTc-HMPAO as perfusion marker are reported. Three patients exhibited reduced tracer uptake in the contralateral basal ganglia One patient who was under therapy for 1 year, showed a different perfusion pattern with reduced uptake in both basal ganglia. These results might indicate reduced perfusion secondary to reduced striatal neuronal activity.

Vorläufige Ergebnisse von 99mTc-HMPAO-SPECT-Untersuchungen bei endogenen Psychosen

1989 ◽  
Vol 28 (03) ◽  
pp. 88-91
Author(s):  
J. Schröder ◽  
H. Henningsen ◽  
H. Sauer ◽  
P. Georgi ◽  
K.-R. Wilhelm
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Regional Cerebral Blood Flow ◽  
Regions Of Interest ◽  
Post Mortem ◽  
Regional Cerebral Blood ◽  
Hmpao Spect ◽  
Endogenous Psychoses ◽  
The Brain ◽  
99Mtc Hmpao

18 psychopharmacologically treated patients (7 schizophrenics, 5 schizoaffectives, 6 depressives) were studied using 99mTc-HMPAO-SPECT of the brain. The regional cerebral blood flow was measured in three transversal sections (infra-/supraventricular, ventricular) within 6 regions of interest (ROI) respectively (one frontal, one parietal and one occipital in each hemisphere). Corresponding ROIs of the same section in each hemisphere were compared. In the schizophrenics there was a significantly reduced perfusion in the left frontal region of the infraventricular and ventricular section (p < 0.02) compared with the data of the depressives. The schizoaffectives took an intermediate place. Since the patients were treated with psychopharmaca, the result must be interpreted cautiously. However, our findings seem to be in accordance with post-mortem-, CT- and PET-studies presented in the literature. Our results suggest that 99mTc-HMPAO-SPECT may be helpful in finding cerebral abnormalities in endogenous psychoses.

123J-Iomazenil- und 99mTc-HMPAO in der Diagnostik fokaler Epilepsien: Vergleich von unbehandelten und behandelten Patienten

1994 ◽  
Vol 33 (01) ◽  
pp. 01-07
Author(s):  
M. Cordes ◽  
B. Schmitz ◽  
J. Hierholzer ◽  
R. Siekmann ◽  
U. Keske ◽  
...  
Keyword(s):  
Hmpao Spect ◽  
99Mtc Hmpao

ZusammenfassungDie Daten von insgesamt 20 Patienten mit fokalen Epilepsien (beh.: 7; unbeh.: 13) wurden mit dem Ziel ausgewertet, Unterschiede in der Bindung der Radiotracer HMPAO und IM घ zwischen behandelten und unbehandelten Patienten herauszufinden. CT und MIRT zeigten keine pathologischen Befunde. Bei allen Patienten wurden mittels SPECT die Gesamthirnaktivität und durch Anwendung der ROI-Technik regionale Impulsdichten (Rl) bestimmt und der spezifische und unspezifische Anteil der Rl des BZ-Antagonisten für jede Region berechnet. In der Gruppe der beh. Patienten konnte eine signifikant höhere normalisierte Gesamtbindung von IMZ gefunden werden (p <0,001). Die spezifische Bindung von IMZ und die Gesamtbindung von HMPAO zeigten keine Unterschiede zwischen beiden Gruppen. Die IMZ-SPECT hatte in unserem Kollektiv gegenüber der HMPAO-SPECT in bezug auf das EEG eine höhere Sensitivität bei geringerer Spezifität im Nachweis einer Minderanreicherung des Tracers in Arealen mit fokaler hypersynchroner Erregungssteigerung.

Vergleich von Blutfluß und Benzodiazepin-Rezeptorverteilung bei fokaler Epilepsie: Vorläufige Ergebnisse einer SPECT-Studie

1989 ◽  
Vol 28 (05) ◽  
pp. 181-186
Author(s):  
A. Ludolph ◽  
O. Schober ◽  
G. Lottes ◽  
I. Böttger ◽  
H.-F. Beer ◽  
...  
Keyword(s):  
Human Brain ◽  
Receptor Binding ◽  
Brain Area ◽  
Brain Perfusion ◽  
Partial Epilepsy ◽  
Cerebral Lesion ◽  
Receptor Ligand ◽  
Receptor Mapping ◽  
Hmpao Spect ◽  
99Mtc Hmpao

99mTc-HMPAO-SPECT and SPECT with the 123I-labelled benzodiazepine (Bz) receptor ligand Ro 16-0154 were performed in 10 patients suffering from partial epilepsy, without cerebral lesion in MRT or CT. 2 h p.i. of Ro 16-0154 the distribution of activity correlated with the known distribution of Bz- receptors in the human brain. Perfusion and receptor-binding were found decreased in 7 patients of each study in the suspicious brain-area. 123l-labelled Ro 16-0154 is suitable for Bz-receptor mapping by SPECT. The decrease of Bz-receptor binding in epileptic foci, as described in PET-studies, was also detected by SPECT in 7 of 10 patients.

Kortikale Dysplasie als epileptogener Fokus: Verminderte Bindung von I-Iomazenil bei unauffälliger 99mTc-HMPAO SPECT

1992 ◽  
Vol 31 (04) ◽  
pp. 142-144
Author(s):  
C. Lehmenkühler ◽  
J. Sciuk ◽  
G. Schuierer ◽  
P. Bartenstein
Keyword(s):  
Hmpao Spect ◽  
99Mtc Hmpao

ZusammenfassungIn kortikalen Arealen, die einem epileptischen Fokus assoziiert sind, korreliert meist eine verminderte Benzodiazepin-Rezeptorbindung, darstellbar mit 123I- Iomazeml, mit einer Minderung des regionalen zerebralen Blutflusses. Anhand eines Fallbeispiels mit ausgeprägter Minderung der 123l-lomazenilbindung im epileptischen Fokus bei ungestörtem regionalen zerebralen Blutfluß wird illustriert und diskutiert, daß bei einer Minderanreicherung von 123I-Iomazenil im epileptischen Fokus eine Alteration des GABAergen Systems anzunehmen ist.

Diagnostik der SDAT mittels HMPAO-SPECT und Serumvitamin-B12-Spiegel

1995 ◽  
Vol 34 (03) ◽  
pp. 104-109 ◽  
Author(s):  
H. J. Gallowitsch ◽  
I. Gomez ◽  
E. Kresnik ◽  
H. Plöb ◽  
P. Lind ◽  
...  
Keyword(s):  
Vitamin B12 ◽  
Hmpao Spect ◽  
99Mtc Hmpao

ZusammenfassungDie alleinige klinische Abklärung dementieller Zustandsbilder, so auch der senilen Demenz vom Alzheimertyp (SDAT), ist schwierig. Durch die Kombination von 99mTc-HMPAO-Gehirn-SPECT und Serumvitamin-B12-Bestimmung erwarteten wir eine Beschleunigung und Verbesserung der Diagnostik der SDAT. Von 116 Patienten, die in 4 Gruppen, entsprechend ihrem 99mTc-HMPAO-Verteilungsmuster eingeteilt worden waren, konnten bei 17 klinisch sehr wahrscheinlichen SDAT-Patienten bei 15 Auffälligkeiten mit Hinweis auf SDAT im Gehirn SPECT gefunden werden. Ein Teil der Patienten wies einen niedrig-normalen bzw. pathologisch niedrigen Vitamin-B12-Spiegel auf. Andere Untersuchungen würden durch die Kombination von Gehirn-SPECT und Serumvitamin-B12-Bestimmung nicht überflüssig werden, obwohl beide Untersuchungen Informationen lieferten, die die Zuordnung zur Diagnose SDAT erleichterten. Die zusätzliche Serumvitamin-B12-Bestimmung stellt keinen wesentlichen Mehraufwand dar.

Sign in / Sign up

Export Citation Format

Share Document